These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28811001)

  • 41. Tufted angioma associated with Kasabach-Merritt phenomenon: a therapeutic challenge.
    Ferrandiz-Pulido C; Mollet J; Sabado C; Ferrer B; Garcia-Patos V
    Acta Derm Venereol; 2010 Sep; 90(5):535-7. PubMed ID: 20814640
    [No Abstract]   [Full Text] [Related]  

  • 42. Topical timolol in nasal tip hemangioma: a viable alternative to systemic therapy.
    Sarkar R; Sethi S; Garg VK
    Int J Dermatol; 2015 Jun; 54(6):e239-41. PubMed ID: 26010405
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1) ) in two patients with tuberous sclerosis.
    Mutizwa MM; Berk DR; Anadkat MJ
    Br J Dermatol; 2011 Oct; 165(4):922-3. PubMed ID: 21692776
    [No Abstract]   [Full Text] [Related]  

  • 44. Tufted angioma arising at the site of hepatitis B vaccination: A case report.
    Sepaskhah M; Hajizadeh J; Sari-Aslani F; Jowkar F
    Turk J Pediatr; 2018; 60(2):188-190. PubMed ID: 30325126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. First left-right comparative study of topical rapamycin vs. vehicle for facial angiofibromas in patients with tuberous sclerosis complex.
    Tanaka M; Wataya-Kaneda M; Nakamura A; Matsumoto S; Katayama I
    Br J Dermatol; 2013 Dec; 169(6):1314-8. PubMed ID: 23909960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
    Jahnel J; Lackner H; Reiterer F; Urlesberger B; Urban C
    Klin Padiatr; 2012 Oct; 224(6):395-7. PubMed ID: 23070861
    [No Abstract]   [Full Text] [Related]  

  • 47. Topical ophthalmic solution in infantile hemangioma.
    Jha AK; Mallik SK; Raihan M
    J Postgrad Med; 2012; 58(2):163-5. PubMed ID: 22718070
    [No Abstract]   [Full Text] [Related]  

  • 48. Response of tufted angiomas to low-dose aspirin.
    Javvaji S; Frieden IJ
    Pediatr Dermatol; 2013; 30(1):124-7. PubMed ID: 22429045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical timolol for small infantile hemangioma: a new therapy option.
    Weissenstein A; Straeter A; Villalon G; Bittmann S
    Turk J Pediatr; 2012; 54(2):156-8. PubMed ID: 22734302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of topical sirolimus in the management of multiple familial trichoepitheliomas.
    Tu JH; Teng JM
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28133868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of intralesional bleomycin in the treatment of complicated hemangiomas: prospective clinical study.
    Omidvari S; Nezakatgoo N; Ahmadloo N; Mohammadianpanah M; Mosalaei A
    Dermatol Surg; 2005 May; 31(5):499-501. PubMed ID: 15962730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis.
    Cinar SL; Kartal D; Bayram AK; Canpolat M; Borlu M; Ferahbas A; Per H
    Indian J Dermatol Venereol Leprol; 2017; 83(1):27-32. PubMed ID: 27643542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of topical timolol treatment of infantile haemangioma: a prospective trial.
    Borok J; Gangar P; Admani S; Proudfoot J; Friedlander SF
    Br J Dermatol; 2018 Jan; 178(1):e51-e52. PubMed ID: 28771668
    [No Abstract]   [Full Text] [Related]  

  • 54. Outcome with topical sirolimus for port wine stain malformations after unsatisfactory results with pulse dye laser treatment alone.
    Musalem HM; Alshaikh AA; Tuleimat LM; Alajlan S
    Ann Saudi Med; 2018; 38(5):376-380. PubMed ID: 30284993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of topical application of eosin for ulcerated hemangiomas.
    Lapidoth M; Ben-Amitai D; Bhandarkar S; Fried L; Arbiser JL
    J Am Acad Dermatol; 2009 Feb; 60(2):350-1. PubMed ID: 19150285
    [No Abstract]   [Full Text] [Related]  

  • 56. Topical timolol for infantile hemangiomas: putting a note of caution in "cautiously optimistic".
    McMahon P; Oza V; Frieden IJ
    Pediatr Dermatol; 2012; 29(1):127-30. PubMed ID: 22256996
    [No Abstract]   [Full Text] [Related]  

  • 57. Can topical beta-blockers reduce the size of superficial infantile hemangiomas of the head and neck?
    Bly RA; Perkins J; Parikh SR
    Laryngoscope; 2017 Jan; 127(1):4-5. PubMed ID: 27808405
    [No Abstract]   [Full Text] [Related]  

  • 58. Acneiform Lesion: Importance of Detailed Skin Examination.
    Samanta D
    Indian J Pediatr; 2016 May; 83(5):485-6. PubMed ID: 26558921
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex.
    Wataya-Kaneda M; Tanaka M; Yang L; Yang F; Tsuruta D; Nakamura A; Matsumoto S; Hamasaki T; Tanemura A; Katayama I
    JAMA Dermatol; 2015 Jul; 151(7):722-30. PubMed ID: 25692384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experience with topical timolol maleate for the treatment of ulcerated infantile hemangiomas (IH).
    Boos MD; Castelo-Soccio L
    J Am Acad Dermatol; 2016 Mar; 74(3):567-70. PubMed ID: 26892656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.